Dr Suzette Coat

 Position Senior Clinical Trial Coordinator
 Org Unit Women's and Children's Health
 Email suzette.coat@adelaide.edu.au
 Telephone +61 8 8313 1338
 Location Floor/Room 3 ,  WCH - Norwich Centre ,   Womens & Childrens Hospital

  • Qualifications

    2011   Specialist Certificate in Clinical Research-Clinical Trial Monitoring, The University of Melbourne

    1998   Ph.D. in Microbiology, Flinders University of South Australia

    1986   B.Sc. Honours, Flinders University of South Australia

    1985   B.Sc. Flinders University of South Australia

  • Awards & Achievements

    2015 Robinson research Institute Seed Funding Grant $25,000

    2015 Robinson Research Institute Travel Grant $850

  • Publications

    Wouldes T, Battin M, Coat S, Rush EC, Hague WM, Rowan JA.  Neurodevelopmental outcomes at 2 years in offspring of women randomised to metformin or insulin treatment for gestational diabetes. Arch Dis Child Fetal NeonatalED 2016;F1-F6. doi:10.1136/archdischild-2015-309602

    Battin MR, Obolonkin V, Rush E, Hague W, Coat S, Rowan J. Blood pressure measurement at two years in offspring of women randomized to a trial of metformin for GDM: Follow up data from the MiG trial. BMC Pediatrics 2015, 15:54 doi:10.1186/s12887-015-0372-1

    Rodger MA, Hague WM, Kingdom J, Kahn SR, Karovitch A, Sermer M, Clement AM, Coat S, Chan WS, Said J, Rey E, Robinson S, Khurana R, Demers C, Kovacs MJ, Solymoss S, Hinshaw K, Dwyer J, Smith G, McDonald S, Newstead-Angel J, McLeod A, Khandelwal M, Silver RM, Le Gal G, Greer IA, Keely E, Rosene-Montella K, Walker M, Wells PS; for the TIPPS Investigators. Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial.  The Lancet 2014, 384(9955):1673-1683. doi.org/10.1016/S0140-6736(14)60793-5.

    Barrett HL, Gatford KL, Houda CM, De Blasio MJ, McIntyre HD, Callaway LK, Dekker Nitert M, Coat S, Owens JA, Hague WM, Rowan JA. Maternal and neonatal circulating markers of metabolic and cardiovascular risk in the Metformin in Gestational Diabetes (MiG) trial: Responses to maternal metformin versus insulin treatment. Diabetes Care. 2013, 36(3):529-36. doi: 10.2337/dc12-1097.

    Barrett HL, Dekker Nitert M, Jones L, O'Rourke P, Lust K, Gatford KL, De Blasio MJ, Coat S, Owens JA, Hague WM, McIntyre HD, Callaway L, Rowan J. Determinants of maternal triglycerides in women with gestational diabetes mellitus in the Metformin in Gestational Diabetes (MiG) Study.  Diabetes Care. 2013, 36(7):1941-6. doi: 10.2337/dc12-2132

    Gatford KL, Houda CM, Lu ZX, Coat S, Baghurst PA, Owens JA, Sikaris K, Rowan JA, Hague WM. Vitamin B12 and homocysteine status during pregnancy in the metformin in gestational diabetes trial: responses to maternal metformin compared with insulin treatment. Diabetes Obes Metab. 2013, 15(7):660-7. doi: 10.1111/dom.12080.

    O’Keefe, M., Coat, S. Increasing health-care options: The perspectives of parents who use complementary and alternative medicines. Journal of Paediatrics and Child Health 2010, 46(6):296-300. doi 10.1111/j.1440-1754.2010.01711.

    Tieu, J., Coat, S., Hague, W., Middleton, P.  Oral anti-diabetic agents for women with pre-existing diabetes mellitus/impaired glucose tolerance or previous gestational diabetes mellitus.  Cochrane Database Syst Rev. 2010 Oct 6;(10):CD007724.

    O’Keefe, M., Coat, S., Jones, A.  The medical education priorities of parents who use Complementary and alternative medicine.  Complementary Health Practice Review 2009; 14: 70-83.

    O’Keefe, M., Coat, S.  Consulting parents on childhood obesity and implications for medical student learning.  Journal of Paediatrics and Child Health 2009; 45: 573-576

The information in this directory is provided to support the academic, administrative and business activities of the University of Adelaide. To facilitate these activities, entries in the University Phone Directory are not limited to University employees. The use of information provided here for any other purpose, including the sending of unsolicited commercial material via email or any other electronic format, is strictly prohibited. The University reserves the right to recover all costs incurred in the event of breach of this policy.

Entry last updated: Tuesday, 29 Mar 2022

To link to this page, please use the following URL:  /directory/suzette.coat